Mariner’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
21,815
+9,174
| +73% | +$4.82M | 0.02% | 560 |
|
|
2025
Q1 | $8.02M | Buy |
12,641
+1,053
| +9% | +$668K | 0.01% | 631 |
|
|
2024
Q4 | $8.25M | Sell |
11,588
-140
| -1% | -$99.7K | 0.01% | 610 |
|
|
2024
Q3 | $12.3M | Buy |
11,728
+899
| +8% | +$944K | 0.02% | 479 |
|
|
2024
Q2 | $11.4M | Sell |
10,829
-129
| -1% | -$136K | 0.02% | 481 |
|
|
2024
Q1 | $10.5M | Buy |
10,958
+372
| +4% | +$358K | 0.02% | 498 |
|
|
2023
Q4 | $9.3M | Buy |
10,586
+3,068
| +41% | +$2.69M | 0.02% | 493 |
|
|
2023
Q3 | $6.19M | Buy |
7,518
+214
| +3% | +$176K | 0.02% | 577 |
|
|
2023
Q2 | $5.25M | Buy |
7,304
+220
| +3% | +$158K | 0.01% | 633 |
|
|
2023
Q1 | $5.82M | Buy |
7,084
+844
| +14% | +$693K | 0.02% | 583 |
|
|
2022
Q4 | $4.5M | Buy |
6,240
+325
| +5% | +$234K | 0.01% | 646 |
|
|
2022
Q3 | $4.08M | Buy |
+5,915
| New | +$4.08M | 0.02% | 567 |
|
|
2019
Q2 | – | Sell |
-857
| Closed | -$352K | – | 1137 |
|
|
2019
Q1 | $352K | Buy |
857
+134
| +19% | +$55K | 0.01% | 760 |
|
|
2018
Q4 | $270K | Buy |
+723
| New | +$270K | ﹤0.01% | 695 |
|